CERo Therapeutics Holdings Inc (NASDAQ: CERO) kicked off on Tuesday, up 188.73% from the previous trading day, before settling in for the closing price of $6.87. Over the past 52 weeks, CERO has traded in a range of $6.71-$895.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 73.05%. With a float of $0.36 million, this company’s outstanding shares have now reached $0.52 million.
In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
CERo Therapeutics Holdings Inc (CERO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of CERo Therapeutics Holdings Inc is 29.58%, while institutional ownership is 6.79%. The most recent insider transaction that took place on Dec 13 ’24, was worth 179,934. In this transaction 10% Owner of this company sold 2,998,908 shares at a rate of $0.06, taking the stock ownership to the 13,005,169 shares. Before that another transaction happened on Dec 12 ’24, when Company’s 10% Owner sold 1,614,541 for $0.07, making the entire transaction worth $113,018. This insider now owns 16,004,077 shares in total.
CERo Therapeutics Holdings Inc (CERO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 73.05% per share during the next fiscal year.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Take a look at CERo Therapeutics Holdings Inc’s (CERO) current performance indicators. Last quarter, stock had a quick ratio of 0.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -498.80, a number that is poised to hit -13.38 in the next quarter and is forecasted to reach -28.47 in one year’s time.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
Looking closely at CERo Therapeutics Holdings Inc (NASDAQ: CERO), its last 5-days average volume was 11.6 million, which is a jump from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 29.27%. Additionally, its Average True Range was 2.57.
During the past 100 days, CERo Therapeutics Holdings Inc’s (CERO) raw stochastic average was set at 23.06%, which indicates a significant decrease from 64.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 456.48% in the past 14 days, which was higher than the 217.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.66, while its 200-day Moving Average is $112.01. However, in the short run, CERo Therapeutics Holdings Inc’s stock first resistance to watch stands at $27.76. Second resistance stands at $35.70. The third major resistance level sits at $44.40. If the price goes on to break the first support level at $11.12, it is likely to go to the next support level at $2.42.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Key Stats
The company with the Market Capitalisation of 10.22 million has total of 386K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -8,300 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -5,110 K.
